DANIELLE REUILLARD: Open Payments
NPI 1285374678 · SOUTH PORTLAND, ME. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,116 in 48 payments from 15 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $1,116
Food & beverage: $959Education: $157
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 10 | $169 |
| Lundbeck LLC | 10 | $166 |
| JAZZ PHARMACEUTICALS INC. | 7 | $162 |
| Dexcom, Inc. | 1 | $158 |
| Teva Pharmaceuticals USA, Inc. | 4 | $133 |
| Amneal Pharmaceuticals LLC | 3 | $77 |
| Neurelis, Inc. | 3 | $61 |
| Eisai Inc. | 3 | $56 |
| UCB, Inc. | 1 | $25 |
| Novartis Pharmaceuticals Corporation | 1 | $23 |
Products named: VYEPTI, XYWAV, DEXCOM G7 GSS (161), QULIPTA, CREXONT, VALTOCO, BOTOX, Leqembi.
Industry payments across ME — which companies pay providers there.
